BioAtla, Inc. (BCAB)
NASDAQ: BCAB · IEX Real-Time Price · USD
2.830
-0.270 (-8.71%)
At close: May 17, 2024, 4:00 PM
2.890
+0.060 (2.12%)
After-hours: May 17, 2024, 5:56 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $136.89 million as of May 17, 2024. Its market cap has decreased by -10.53% in one year.
Market Cap
136.89M
Enterprise Value
58.18M
1-Year Change
-10.53%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $136.89M, a decrease of -76.30%. That is a compound annual growth rate of -34.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 136.20M | -8.71% |
| May 16, 2024 | 149.20M | 3.40% |
| May 15, 2024 | 144.30M | 14.89% |
| May 14, 2024 | 125.60M | -1.10% |
| May 13, 2024 | 127.00M | -2.53% |
| May 10, 2024 | 130.30M | -6.93% |
| May 9, 2024 | 140.00M | -6.98% |
| May 8, 2024 | 150.50M | 1.28% |
| May 7, 2024 | 148.60M | -2.56% |
| May 6, 2024 | 152.50M | -2.43% |
| May 3, 2024 | 156.30M | 2.83% |
| May 2, 2024 | 152.00M | -6.23% |
| May 1, 2024 | 162.10M | 49.40% |
| Apr 30, 2024 | 108.50M | -12.57% |
| Apr 29, 2024 | 124.10M | 1.55% |
| Apr 26, 2024 | 122.20M | 12.94% |
| Apr 25, 2024 | 108.20M | -4.25% |
| Apr 24, 2024 | 113.00M | 4.92% |
| Apr 23, 2024 | 107.70M | 2.67% |
| Apr 22, 2024 | 104.90M | 3.66% |
| Apr 19, 2024 | 101.20M | -13.43% |
| Apr 18, 2024 | 116.90M | -3.94% |
| Apr 17, 2024 | 121.70M | -3.64% |
| Apr 16, 2024 | 126.30M | -8.21% |
| Apr 15, 2024 | 137.60M | -8.57% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 139.38M |
| aTyr Pharma | 138.02M |
| Sangamo Therapeutics | 137.79M |
| DBV Technologies | 137.60M |
| InfuSystem Holdings | 137.51M |
| Renovaro Biosciences | 136.53M |
| Tevogen Bio Holdings | 136.25M |
| Seer, Inc. | 135.39M |